Product Program year 2025 Source: CMS Open Payments

GORE VIABAHN VBX Balloon Expandable Endo

Device Devices

PDI 00733132637065

Open in the dashboard

General payments

$1,899,832

12,724 payments

Research payments

$0

0 payments

Through program year 2025, $1,899,832 in general payments and $0 in research payments were reported against GORE VIABAHN VBX Balloon Expandable Endo (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $571,729 3,152
2024 General $550,981 3,374
2023 General $400,294 2,530
2022 General $288,690 2,251
2021 General $88,138 1,417

Breakdown

Who paid General payments · program years 2021–2025
  1. W. L. Gore & Associates, Inc. $1,899,832 12,724 payments
Top recipients General payments · program year 2025
  1. Prakash Krishnan Interventional Cardiology · New York, NY $28,286 5% · 18 payments
  2. Washington Hospital Center Teaching hospital · DC $27,500 5% · 2 payments
  3. Ajit Rao Vascular Surgery · New York, NY $25,118 4% · 21 payments
  4. Venita Chandra Vascular Surgery · Palo Alto, CA $22,062 4% · 18 payments
  5. Richard Neville Vascular Surgery · Falls Church, VA $21,961 4% · 14 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $370,432 68% · 851 practitioners
  2. Interventional Cardiology Internal Medicine $85,574 16% · 93 practitioners
  3. Vascular & Interventional Radiology Radiology $21,386 4% · 95 practitioners
  4. Surgery $20,737 4% · 149 practitioners
  5. Diagnostic Radiology Radiology $12,208 2% · 53 practitioners

The top 5 of 45 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $99,189 17% · 81 recipients
  2. Pennsylvania $48,218 8% · 109 recipients
  3. California $47,645 8% · 126 recipients
  4. Florida $34,720 6% · 150 recipients
  5. Texas $34,223 6% · 199 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

12,724 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record